XML 45 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplemental Financial Information
12 Months Ended
Dec. 30, 2023
Supplemental Financial Information [Abstract]  
Additional Financial Information Disclosure [Text Block] Supplemental Financial Information
Balance Sheet
202320222021
Accounts and notes receivable (a)
Trade receivables$8,675 $8,192 
Other receivables2,315 2,121 
Total10,990 10,313 
Allowance, beginning of year150 147 $201 
Net amounts charged to expense (b)
55 21 (19)
Deductions (c)
(26)(12)(25)
Other (d)
(4)(6)(10)
Allowance, end of year175 150 $147 
Accounts and notes receivable, net$10,815 $10,163 
Property, plant and equipment, netAverage
Useful Life (Years)
Land $1,159 $1,142 
Buildings and improvements
15 - 44
11,579 10,816 
Machinery and equipment, including fleet and software
5 - 15
36,006 33,335 
Construction in progress5,695 4,491 
54,439 49,784 
Accumulated depreciation(27,400)(25,493)
Property, plant and equipment, net (e)
$27,039 $24,291 
Depreciation expense$2,714 $2,523 $2,484 
Other assets
Noncurrent notes and accounts receivable$200 $202 
Deferred marketplace spending103 123 
Pension plans (f)
1,057 948 
Right-of-use assets (g)
2,905 2,373 
Other investments (h)
1,616 813 
Other780 833 
Total$6,661 $5,292 
Accounts payable and other current liabilities
Accounts payable (i)
$11,635 $10,732 
Accrued marketplace spending3,523 3,637 
Accrued compensation and benefits2,687 2,519 
Dividends payable1,767 1,610 
Current lease liabilities (g)
556 483 
Other current liabilities (j)
4,969 4,390 
Total$25,137 $23,371 
(a)Increase primarily reflects strong revenue performance across much of our portfolio in 2023.
(b)2021 includes reductions in allowance for expected credit losses related to COVID-19 pandemic recorded in 2020.
(c)Includes accounts written off.
(d)Includes adjustments related primarily to currency translation and other adjustments.
(e)Change is driven by increase in capital spending, partially offset by depreciation.
(f)See Note 7 for further information.
(g)See Note 12 for further information.
(h)Increase in 2023 primarily reflects unrealized pre-tax gains on our investment in Celsius convertible preferred stock. See Note 9 for further information.
(i)Increase reflects higher capital expenditures and commodity costs in 2023.
(j)Increase primarily reflects change in income tax provision. See Note 5 for further information.
Statement of Cash Flows
202320222021
Interest paid (a)
$1,401 $1,043 $1,184 
Income taxes paid, net of refunds (b)
$2,532 $2,766 $1,933 
(a)2022 excludes the premiums paid in accordance with the debt transactions. 2021 excludes the charge related to cash tender offers. See Note 8 for further information.
(b)In each of 2023, 2022 and 2021, includes tax payments of $309 million related to the TCJ Act.

Supplemental Non-Cash Activity
202320222021
Debt discharged via legal defeasance$94 $— $— 

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement:
20232022
Cash and cash equivalents$9,711 $4,954 
Restricted cash included in other assets (a)
50 146 
Total cash and cash equivalents and restricted cash$9,761 $5,100 
    
(a)Primarily relates to collateral posted against certain of our derivative positions.